Ovid Therapeutics Inc. - OVID
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jul 08, 2026 | Chief Financial Officer | A | A | 50,000.0 | 0.0 | 0.0 | 94,375.0 | View | |
| Jun 17, 2026 | — | A | A | 130,000.0 | 0.0 | 0.0 | 130,000.0 | View | |
| Apr 09, 2026 | — | A | A | 8,789.0 | 2.56 | 22,499.84 | 8,789.0 | View | |
| Apr 09, 2026 | — | A | A | 17,578.0 | 2.56 | 44,999.68 | 17,578.0 | View | |
| Apr 09, 2026 | — | A | A | 17,578.0 | 2.56 | 44,999.68 | 217,578.0 | View | |
| Mar 25, 2026 | Executive Chairman | M | D | 47,333.0 | 0.0 | 0.0 | 0.0 | View | |
| Mar 25, 2026 | Executive Chairman | M | A | 47,333.0 | 1.4 | 66,266.2 | 3,735,048.0 | View | |
| Mar 02, 2026 | — | A | A | 65,000.0 | 0.0 | 0.0 | 65,000.0 | View | |
| Mar 02, 2026 | — | A | A | 65,000.0 | 0.0 | 0.0 | 65,000.0 | View | |
| Mar 02, 2026 | — | A | A | 65,000.0 | 0.0 | 0.0 | 65,000.0 | View | |
| Mar 02, 2026 | CBFO | A | A | 408,750.0 | 0.0 | 0.0 | 408,750.0 | View | |
| Mar 02, 2026 | CBFO | A | A | 68,125.0 | 0.0 | 0.0 | 156,313.0 | View | |
| Mar 02, 2026 | CBFO | S | D | 8,541.0 | 1.45 | 12,384.45 | 88,188.0 | View | |
| Mar 02, 2026 | — | A | A | 957,000.0 | 0.0 | 0.0 | 957,000.0 | View | |
| Mar 02, 2026 | — | A | A | 65,000.0 | 0.0 | 0.0 | 65,000.0 | View | |
| Mar 02, 2026 | — | A | A | 65,000.0 | 0.0 | 0.0 | 65,000.0 | View | |
| Mar 02, 2026 | President and CEO | A | A | 1,435,000.0 | 0.0 | 0.0 | 1,435,000.0 | View | |
| Mar 02, 2026 | President and CEO | S | D | 11,656.0 | 1.45 | 16,901.2 | 61,750.0 | View |